Envista Holdings Corp
NVST20.980USD
+0.150+0.72%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
3.50BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Envista Holdings Corp Unternehmen
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Unternehmensinformationen
BörsenkürzelNVST
Name des UnternehmensEnvista Holdings Corp
IPO-datumSep 18, 2019
CEOMr. Paul A. Keel
Anzahl der mitarbeiter12300
WertpapierartOrdinary Share
GeschäftsjahresendeSep 18
Addresse200 S. Kraemer Blvd., Bldg. E
StadtBREA
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl92821
Telefon17148175418
Websitehttps://envistaco.com/en
BörsenkürzelNVST
IPO-datumSep 18, 2019
CEOMr. Paul A. Keel
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
55.74K
+22.64%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
55.74K
+22.64%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-4.05%
Mr. J. Andrew Pierce
Mr. J. Andrew Pierce
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
55.74K
+22.64%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
55.74K
+22.64%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Northern America
324.40M
52.59%
Western Europe
143.30M
23.23%
Emerging markets
118.80M
19.26%
Other developed markets
30.40M
4.93%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, May 17
Aktualisiert: Sat, May 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
9.28%
Ariel Investments, LLC
7.31%
Atlanta Capital Management Company, L.L.C.
7.31%
Dimensional Fund Advisors, L.P.
5.52%
Other
60.34%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
9.28%
Ariel Investments, LLC
7.31%
Atlanta Capital Management Company, L.L.C.
7.31%
Dimensional Fund Advisors, L.P.
5.52%
Other
60.34%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
58.23%
Investment Advisor/Hedge Fund
45.40%
Hedge Fund
8.82%
Research Firm
1.42%
Pension Fund
1.41%
Sovereign Wealth Fund
1.21%
Bank and Trust
0.61%
Individual Investor
0.55%
Family Office
0.05%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
734
200.23M
118.14%
-35.42M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
2023Q2
772
187.89M
114.71%
-18.52M
2023Q1
783
191.23M
116.82%
-14.97M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
17.02M
10.04%
-218.34K
-1.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
15.43M
9.1%
+235.82K
+1.55%
Mar 31, 2025
Ariel Investments, LLC
12.14M
7.17%
+85.12K
+0.71%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
12.14M
7.16%
+242.93K
+2.04%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.39M
4.95%
+1.63M
+24.03%
Mar 31, 2025
Harris Associates L.P.
8.68M
5.12%
-740.06K
-7.86%
Mar 31, 2025
Franklin Mutual Advisers, LLC
7.67M
4.52%
+817.48K
+11.93%
Mar 31, 2025
American Century Investment Management, Inc.
6.35M
3.75%
-552.57K
-8.00%
Mar 31, 2025
State Street Global Advisors (US)
5.68M
3.35%
+33.13K
+0.59%
Mar 31, 2025
Victory Capital Management Inc.
5.44M
3.21%
+3.35M
+161.26%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
SPDR S&P Health Care Equipment ETF
1.85%
Schwab Ariel Opportunities ETF
1.24%
Royce Quant Small-Cap Quality Value ETF
0.56%
JPMorgan Fundamental Data Science Mid Core ETF
0.55%
Pacer US Small Cap Cash Cows ETF
0.38%
iShares U.S. Medical Devices ETF
0.38%
Gotham 1000 Value ETF
0.36%
VictoryShares US Small Mid Cap Value Momentum ETF
0.32%
Global X US Cash Flow Kings 100 ETF
0.32%
DFA Dimensional US Small Cap Value ETF
0.26%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil1.85%
Schwab Ariel Opportunities ETF
Anteil1.24%
Royce Quant Small-Cap Quality Value ETF
Anteil0.56%
JPMorgan Fundamental Data Science Mid Core ETF
Anteil0.55%
Pacer US Small Cap Cash Cows ETF
Anteil0.38%
iShares U.S. Medical Devices ETF
Anteil0.38%
Gotham 1000 Value ETF
Anteil0.36%
VictoryShares US Small Mid Cap Value Momentum ETF
Anteil0.32%
Global X US Cash Flow Kings 100 ETF
Anteil0.32%
DFA Dimensional US Small Cap Value ETF
Anteil0.26%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
